# Acetazolamide for the Prevention of High Altitude Illness: a Comparison of Dosing

> **NCT01993667** · PHASE4 · COMPLETED · sponsor: **University of Utah** · enrollment: 130 (actual)

## Conditions studied

- Prophylaxis of Acute Mountain Sickness

## Interventions

- **DRUG:** Low Dose Acetazolamide
- **DRUG:** Normal Dose Acetazolamide

## Key facts

- **NCT ID:** NCT01993667
- **Lead sponsor:** University of Utah
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-03
- **Primary completion:** 2016-11
- **Final completion:** 2016-11
- **Target enrollment:** 130 (ACTUAL)
- **Last updated:** 2019-01-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01993667

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01993667, "Acetazolamide for the Prevention of High Altitude Illness: a Comparison of Dosing". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01993667. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*